Meril Life Sciences, a leading global med-tech company with its portfolio in cardiovascular and structural heart solutions, celebrated a remarkable achievement with the launch of its cutting-edge Myval Octapro Transcatheter Heart Valve (THV) at GISE 2024 (National Congress of the Italian Society of Interventional Cardiology)